Asher Bio Funding: $215M Raised, Series C (2024)

Asher Bio funding overview

Asher Bio is based in South San Francisco, CA. Asher Bio has raised $215M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in April 2024. The round record for Asher Bio runs through 2024; nothing later has been disclosed. Investors on record include RA Capital Management, AstraZeneca, Bristol Myers Squibb, Third Rock Ventures, Wellington Management, Logos Capital and 5 others. 11 distinct backers are named across the disclosed rounds.

Asher Bio at a glance

Total raised: $215M
Latest round: Series C
Latest round date: April 2024
Headquarters: South San Francisco, CA
Notable investors: RA Capital Management, AstraZeneca, Bristol Myers Squibb, Third Rock Ventures, Wellington Management, Logos Capital, Marshall Wace, Alexandria Venture Investments

Frequently asked about Asher Bio funding

How much has Asher Bio raised?: Asher Bio has raised $215M in total disclosed funding across the rounds on record.
Who has invested in Asher Bio?: RA Capital Management, AstraZeneca, Bristol Myers Squibb, Third Rock Ventures, Wellington Management, Logos Capital are named among the investors backing Asher Bio.
What was the latest Asher Bio funding round?: The most recent disclosed round is a Series C, announced in April 2024.
Where is Asher Bio based?: Asher Bio is based in South San Francisco, CA.
When did Asher Bio last raise?: The last disclosed Asher Bio round closed in April 2024 at Series C.

Totals shown for Asher Bio aggregate every disclosed round on file. To see how that compares, browse the companies in South San Francisco and the investors behind them below.

Asher Bio Funding: $215M Raised, Series C (2024)

Asher Bio funding overview

Asher Bio at a glance

Frequently asked about Asher Bio funding

Companies related to Asher Bio (35)

Browse related funding lists (9)